<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03238183</url>
  </required_header>
  <id_info>
    <org_study_id>MOST 106-2314-B-341-003</org_study_id>
    <nct_id>NCT03238183</nct_id>
  </id_info>
  <brief_title>Effects of Dextrose on Knee Osteoarthritis</brief_title>
  <official_title>Additional Therapeutic Effects of Dextrose to Hyaluronic Acid on Knee Osteoarthritis: a Double Blind, Randomized-controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taipei Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taipei Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Using double blind, randomized controlled design to study the immediate, short-term and
      intermediate-term therapeutic effects of ultrasound guided hyaluronic acid injection and
      hyaluronic acid combined dextrose injection to patients with knee osteoarthritis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 106 patients will be collected. The participants will be randomized into two
      groups, including hyaluronic acid group and hyaluronic acid combined dextrose group.

      The hyaluronic acid group will receive 3 times of hyaluronic acid injection per week in three
      weeks; the hyaluronic acid combined dextrose group will receive 3 times of hyaluronic acid
      combined dextrose injection per week in three weeks.

      The pain, physical activity, and functional performance will be evaluated.

      All the evaluations will be re-evaluated at one week after injection, one month after
      injection, three months after injection, and six month after injection.

      Subjects and the evaluator will be both blinded to the group's classification during the
      whole course of study.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2017</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>physical activity-on level walking time</measure>
    <time_frame>changes from baseline to at one week after injection, one month after injection, three months after injection, and six month after injection</time_frame>
    <description>10 meter walking</description>
  </primary_outcome>
  <primary_outcome>
    <measure>physical activity-stair climbing time</measure>
    <time_frame>changes from baseline to at one week after injection, one month after injection, three months after injection, and six month after injection</time_frame>
    <description>stairs climbing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>physical activity-chair rising time</measure>
    <time_frame>changes from baseline to at one week after injection, one month after injection, three months after injection, and six month after injection</time_frame>
    <description>chair rising</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>functional performance</measure>
    <time_frame>changes from baseline to at one week after injection, one month after injection, three months after injection, and six month after injection</time_frame>
    <description>Western Ontario and McMaster Universities Osteoarthritis index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life</measure>
    <time_frame>changes from baseline to at one week after injection, one month after injection, three months after injection, and six month after injection</time_frame>
    <description>Knee Injury and Osteoarthritis Outcome Score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">106</enrollment>
  <condition>Physical Activity</condition>
  <condition>Functional Disturbance</condition>
  <arm_group>
    <arm_group_label>hyaluronic acid combined dextrose group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Hyaluronic acid (2 cc) combined 25% dextrose (3.5 cc 50% dextrose plus 3.5 cc 2% lidocaine) injection: one injection per week, for 3 weeks, to compare the additional therapeutic effects of combined hyaluronic acid and dextrose injections to hyaluronic acid injections</description>
  </arm_group>
  <arm_group>
    <arm_group_label>hyaluronic acid group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Hyaluronic acid (2 cc) combined normal saline (3.5 cc normal saline plus 3.5 cc 2% lidocaine) injection: one injection per week, for 3 weeks, to compare the additional therapeutic effects of combined hyaluronic acid and dextrose injections to hyaluronic acid injections</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dextrose</intervention_name>
    <description>compare the therapeutic effects of hyaluronic acid combined dextrose injections with hyaluronic acid injections only to patients with knee osteoarthritis</description>
    <arm_group_label>hyaluronic acid combined dextrose group</arm_group_label>
    <other_name>glucose water</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>hyaluronic acid</intervention_name>
    <description>compare the therapeutic effects of hyaluronic acid combined dextrose injections with hyaluronic acid injections only to patients with knee osteoarthritis</description>
    <arm_group_label>hyaluronic acid combined dextrose group</arm_group_label>
    <arm_group_label>hyaluronic acid group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  knee osteoarthritis with Kellgren/Lawrence grade II or III

        Exclusion Criteria:

          -  who have neurological deficit, such as stroke who have implant in knee
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ru-Lan Hsieh</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shin Kong Wu Ho-Su Memorial Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ru-Lan Hsieh</last_name>
    <phone>228332211</phone>
    <email>M001052@ms.skh.org.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ru-Lan Hsieh</last_name>
    <phone>228332211</phone>
    <email>rulan@tmu.edu.tw</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shin Kong Wu Ho-Su Memorial Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>111-01</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2017</study_first_submitted>
  <study_first_submitted_qc>August 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2017</study_first_posted>
  <last_update_submitted>August 2, 2017</last_update_submitted>
  <last_update_submitted_qc>August 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Taipei Medical University</investigator_affiliation>
    <investigator_full_name>Ru-Lan Hsieh</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>knee osteoarthritis</keyword>
  <keyword>hyaluronic acid</keyword>
  <keyword>dextrose</keyword>
  <keyword>therapeutic effects</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
    <mesh_term>Pathologic Processes</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

